How to
Search
Find
How to
Join
Play Video
Video time control bar
0:00
▶️
⏸️
🔊
Audio volume control bar
0:00
/
0:00
↘️ 0.25
↘️ 0.5
↘️ 0.75
➡️ 1
↗️ 1.25
↗️ 1.5
↗️ 1.75
↗️ 2
↔️
↕️
Timecodes:
Related videos:
ACC 24 Late-Breaker Discussion: The EMPACT-MI Trial
DanGer Shock - First Positive RCT of Impella - Cardiogenic Shock - A critical appraisal
Cardiogenic shock: tips and updates
The complexity in treatment of patients in shock - EuroPCR 2024
Day 2 | ACCess Points Daily Wrap Up at ACC.24
Empagliflozin after acute myocardial infarction: Results of the EMPACT-MI Trial #ACC24
DanGer Shock Impella in Cardiogenic Shock Study Analysis
In DanGer Shock Shock Territory: The Use of Microbial Flow Pump in Cardiogenic Shock From Acute MI
AHA 23 Late-Breaker Discussion: The SELECT Trial
Evolution of complex PCI: cross, modify it, and be precise! - EuroPCR 2024
Shock | Clinical Medicine
ACC Cardiology Hour From ACC.24
Inotropes and Cardiogenic Shock - the DOREMI trial | Benjamin Hibbert, MD, PhD
Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism
Cardiogenic Shock
ACC 24 Late-Breaker Discussion: The AEGIS-II Trial
Cardiogenic Shock: How Physiology has Changed Clinical Practice (Daniel Burkhoff, MD) April 15, 2021
Emory Cardiology Friday Fellows Conference Journal Club 04-19-2024
TAVR vs SAVR in patients at low to intermediate risk: DEDICATE-DZHK6 one year outcomes #ACC24
Shock | Hypovolemic, Cardiogenic, Obstructive, Distributive | Retired